| Identification | Back Directory | [Name]
Ezetimibe-d4 -D-Glucuronide, >85% | [CAS]
NoCAS | [Synonyms]
Sch 60663-d4
Sch 58235-d4 Glucuronide
Ezetimibe-d4 Phenoxy Glucuronide
Ezetimibe-d4 -D-Glucuronide, >85%
4-[(2S,3R)-1-(4-Fluorophenyl-d4)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxo-2-azetidinyl]phenyl-D-Glucopyranosiduronic Acid | [Molecular Formula]
C30H25D4F2NO9 | [MDL Number]
MFCD11977997 | [MOL File]
1426174-41-5.mol | [Molecular Weight]
589.574 |
| Chemical Properties | Back Directory | [Appearance]
White Solid | [Melting point ]
140-150°C | [storage temp. ]
-20°C Freezer | [solubility ]
DMSO (Slightly, Sonicated), Methanol (Very Slightly), Water (Very Slightly) | [form ]
Solid | [color ]
White to Pale Brown | [Stability:]
Hygroscopic |
| Hazard Information | Back Directory | [Chemical Properties]
White Solid | [Uses]
Phase-II labelled metabolite of Ezetimibe, an antihyperlipoproteinemic. A Cholesterol absorption inhibitor | [in vivo]
After oral administration, Ezetimibe is absorbed in the small intestine and more than 80% of Ezetimibe metabolized to Ezetimibe Glucuronide[1]. |
|
|